Maria Claudia Burgos Florez

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Alicia T. Widge, Amelia R. Hofstetter, Katherine V. Houser et al. · Science Translational Medicine · 2023 · 96 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Joseph P. Casazza, Evan M. Cale, Sandeep Narpala et al. · Nature Medicine · 2022 · 94 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung et al. · The Lancet Respiratory Medicine · 2021 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12